Evidence map›Paper›PMID 39854098›Full record

ArticleHead & neck2025

Exploratory Research: Patient-Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer.

Alice Vergauwen, Margot Baudelet, Leen Van den Steen, Ann Goeleven, Sandra Nuyts, Daan Nevens, Hanne Massonet, Fréderic Duprez, Gwen Van Nuffelen

Abstract read
In one paragraph

Article in Head & neck, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alice VergauwenFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.ORCID 0009-0005-0173-5804
Margot BaudeletDepartment of ENT, Ter Sprake, University Hospital Ghent, Ghent, Belgium.
Leen Van den SteenFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Ann GoelevenFaculty of Medicine, Department of Neurosciences, Research Group Experimental Oto-Rhino-Laryngology - Deglutology, KU Leuven, Leuven, Belgium.
Sandra NuytsDepartment of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-5540-4796
Daan NevensFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Hanne MassonetFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Fréderic DuprezFaculty of Medicine and Health Sciences, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Gwen Van NuffelenFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Funding

Kom op tegen Kanker
6 · The paper itself

Abstract

backgroundRadiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation-associated dysphagia (RAD). These factors threaten patients' oral intake (OI) during this RT. Reduced OI can cause weight loss, dehydration, malnutrition, and various comorbidities. On top, reduced OI significantly affects quality of life and may contribute to RAD through the disuse of swallowing muscles. With the aim of maximizing the retention of a patient's OI, it is important to gain an insight into the factors that have the greatest impact. Therefore, this study aims to identify the impact of contributing factors on decreased OI during RT.

methodsDuring their treatment, 55 HNC patients completed an OI questionnaire at 5 different time points: during weeks 1, 2, 3, and 4 and at the end of RT (week 7). First, patients rated the OI compared to pre-RT on a 100 mm visual analogue scale (VAS). Subsequently, patients reported on separate VAS the degree to which pain, fatigue, loss of taste, loss of smell, loss of interest in food, nausea, and loss of hunger contributed to the decrease in OI (0: no contribution; 100: complete contribution). SPSS version 27 was used to analyze the results.

resultsOI decreased over time during RT, with the lowest OI at the end of RT. During the first 4 weeks of RT, the impact of all factors with pain, loss of taste, loss of interest in food, and loss of hunger pointed out as strongest contributing factors to a decreased OI. The most important patient-reported impacting factor on OI was loss of taste. At the end of RT, the importance of pain and nausea still increases, while the contribution of the other factors drops slightly.

conclusionThis cohort study shows that several factors contribute to a decreased OI in HNC patients during RT. This study is the first prospective analysis to identify self-reported factors contributing to reduced OI. Results demonstrate that taste has the greatest impact on OI followed by loss of interest in food, loss of hunger, and pain.

Indexed as

Deglutition DisordersEatingHead and Neck NeoplasmsRadiation InjuriesAdultAgedFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresQuality of LifeSurveys and Questionnairesdysphagiahead–neck canceroral intakepatient‐reportedquality of life

Identifiers

PMID39854098
PMCPMC12068540

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.